123 related articles for article (PubMed ID: 10795142)
1. [Fat control--an effective antihypertensive strategy. Special recommendations for therapy of the overweight patient].
Bönner G
MMW Fortschr Med; 1999 Nov; 141(46):34-6. PubMed ID: 10795142
[TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinemia, insulin resistance, and hypertension.
Bönner G
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
[TBL] [Abstract][Full Text] [Related]
3. Obesity in hypertension: effects on prognosis and treatment.
Kaplan NM
J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095
[TBL] [Abstract][Full Text] [Related]
4. Obesity and hypertension.
Hsueh WA; Buchanan TA
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):405-27. PubMed ID: 8070430
[TBL] [Abstract][Full Text] [Related]
5. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of obesity-related hypertension].
Skoczylas A
Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
[TBL] [Abstract][Full Text] [Related]
7. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
8. Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment.
Richards RJ; Thakur V; Reisin E
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S59-64. PubMed ID: 8872829
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
[TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
11. Hypertension and obesity.
Dustan HP
Prim Care; 1991 Sep; 18(3):495-507. PubMed ID: 1946785
[TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy].
Vázquez Chávez C; Brito Zurita OR; Argüero Sánchez R; Lozano de los Santos H
Gac Med Mex; 1993; 129(5):339-45. PubMed ID: 7926420
[TBL] [Abstract][Full Text] [Related]
13. Hypertension in obesity.
Redon J
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
15. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management.
Farshchi H; Rane A; Love A; Kennedy RL
J Obstet Gynaecol; 2007 Nov; 27(8):762-73. PubMed ID: 18097891
[TBL] [Abstract][Full Text] [Related]
16. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance.
de Jongh RT; Serné EH; IJzerman RG; de Vries G; Stehouwer CD
Circulation; 2004 Jun; 109(21):2529-35. PubMed ID: 15136505
[TBL] [Abstract][Full Text] [Related]
17. [Arterial hypertension and obesity--a dangerous combination].
Zakharieva S
Vutr Boles; 1999; 31(1):28-32. PubMed ID: 10847146
[TBL] [Abstract][Full Text] [Related]
18. Advanced oxidation protein products (AOPPs) in juvenile overweight and obesity prior to and following weight reduction.
Krzystek-Korpacka M; Patryn E; Boehm D; Berdowska I; Zielinski B; Noczynska A
Clin Biochem; 2008 Aug; 41(12):943-9. PubMed ID: 18501708
[TBL] [Abstract][Full Text] [Related]
19. Waist circumference and fat intake are associated with high blood pressure in Mexican children aged 8 to 10 years.
Colín-Ramírez E; Castillo-Martínez L; Orea-Tejeda A; Villa Romero AR; Vergara Castañeda A; Asensio Lafuente E
J Am Diet Assoc; 2009 Jun; 109(6):996-1003. PubMed ID: 19465181
[TBL] [Abstract][Full Text] [Related]
20. Obesity-associated hypertension: hypothesized link between etiology and selection of therapy.
Reisin E; Tuck ML
Blood Press Monit; 1999; 4 Suppl 1():S23-6. PubMed ID: 10822414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
